POINT Biopharma Global Inc.

CIK 1811764 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for POINT Biopharma Global Inc..

Recent SEC filings

FiledFormAccession number
Jan 8, 202415-12G0001193125-24-003853
Dec 29, 2023EFFECT9999999995-24-000026
Dec 29, 2023EFFECT9999999995-24-000028
Dec 27, 202340001104659-23-129770
Dec 27, 202340001104659-23-129776
Dec 27, 202340001104659-23-129772
Dec 27, 202340001104659-23-129773
Dec 27, 2023SC 13D/A0001104659-23-129754
Dec 27, 202340001104659-23-129768
Dec 27, 2023S-8 POS0001193125-23-303575
Dec 27, 202340001104659-23-129777
Dec 27, 2023POS AM0001193125-23-303584
Dec 27, 202340001104659-23-129771
Dec 27, 202340001104659-23-129766
Dec 27, 202340001104659-23-129769
Dec 27, 202325-NSE0001354457-23-001006
Dec 27, 202340001104659-23-129767
Dec 27, 2023S-8 POS0001193125-23-303578
Dec 27, 202340001104659-23-129775
Dec 27, 2023POS AM0001193125-23-303590
Dec 27, 2023S-8 POS0001193125-23-303570
Dec 27, 20238-K0001193125-23-303512
Dec 26, 2023SC TO-T/A0001193125-23-302265
Dec 26, 2023SC 14D9/A0001193125-23-302270
Dec 20, 202340001193805-23-001635